デフォルト表紙
市場調査レポート
商品コード
1472989

医薬品添加剤の世界市場:タイプ別、機能性別、エンドユーザー別、地域別、機会、予測、2017年~2031年

Pharmaceutical Excipients Market Assessment, By Type, By Functionality, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 227 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
医薬品添加剤の世界市場:タイプ別、機能性別、エンドユーザー別、地域別、機会、予測、2017年~2031年
出版日: 2024年05月01日
発行: Market Xcel - Markets and Data
ページ情報: 英文 227 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品添加剤の市場規模は、2024年から2031年の予測期間中に7%のCAGRで拡大し、2023年の111億1,000万米ドルから2031年には190億8,000万米ドルに成長すると予測されています。同市場は近年著しい成長を遂げており、今後も力強い拡大ペースを維持すると予想されます。

世界人口の慢性疾患有病率の増加や高齢者人口の増加など、さまざまな要因が世界の医薬品添加剤市場の成長を後押ししています。ジェネリック医薬品の需要開拓と、公的・民間企業による投資・研究開発活動の活発化が、同市場の成長につながっています。さらに、有利な規制制度、複数のトップ企業の存在、共同事業活動、新規参入、頻繁な新製品の上市が、世界の医薬品添加剤市場の成長を加速させています。

世界の医薬品添加剤市場は力強い成長を遂げていますが、その主な理由は世界人口の間で慢性疾患や感染症が増加していることです。高齢化が進むにつれ、免疫力の低下により慢性疾患や感染症に罹患する確率が高まり、これらの疾患の治療用賦形剤などの医薬品需要がさらに加速しています。製薬業界の成長と医薬品需要の増加に対応するためのジェネリック医薬品の需要の増加は、医薬品賦形剤を使用した創薬への投資に対する製薬会社の関心の高まりにつながっています。新しい効率的な医薬品賦形剤を開発するための市場参入企業による研究開発活動の増加、有利な規制枠組み、市場参入企業による頻繁な製品上市は、世界の医薬品賦形剤市場を強化する上で極めて重要な役割を果たしています。さらに、M&A、パートナーシップ、流通契約などの組織間の一貫した協力活動は、世界の医薬品賦形剤市場をさらに推進しています。例えば、2023年11月、IFFとBASFの医薬品ソリューション部門は、IFFの主要医薬品賦形剤ブランドをBASFのバーチャル医薬品アシスタントプラットフォーム「ZoomLab」に導入するための協業を発表しました。このプラットフォームにより、研究者は新しい医薬品製剤の開発に必要な適切な賦形剤を予測・分析し、製剤の課題を克服することができます。

当レポートでは、世界の医薬品添加剤市場について調査し、市場の概要とともに、タイプ別、機能性別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の医薬品添加剤市場の見通し、2017年~2031年

  • 市場規模と予測
  • タイプ別
  • 機能性別
  • エンドユーザー別
  • 地域別
  • 企業別市場シェア(%)、2023年

第5章 世界の医薬品添加剤市場の見通し、地域別、2017年~2031年

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第6章 2023年の市場マッピング

第7章 マクロ環境と産業構造

  • 需要供給分析
  • 輸出入分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

  • Kerry Group plc.
  • DFE Pharma GmbH & Co KG
  • Cargill, Incorporated
  • BASF SE
  • Roquette Freres
  • Pfanstiehl Inc.
  • MEGGLE GmbH & Co. KG.
  • The Lubrizol Corporation
  • Avantor, Inc.
  • BENEO GmbH

第14章 戦略的提言

第15章 お問い合わせと免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 2.Global Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 3.Global Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 4.Global Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 5.Global Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 6.Global Pharmaceutical Excipients Market Share (%), By Region, 2017-2031F
  • Figure 7.North America Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 8.North America Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 9.North America Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 10.North America Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 11.North America Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 12.North America Pharmaceutical Excipients Market Share (%), By Country, 2017-2031F
  • Figure 13.United States Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 14.United States Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 15.United States Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 16.United States Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 17.United States Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 18.Canada Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 19.Canada Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 20.Canada Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 21.Canada Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 22.Canada Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 23.Mexico Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 24.Mexico Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 25.Mexico Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 26.Mexico Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 27.Mexico Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 28.Europe Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 29.Europe Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 30.Europe Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 31.Europe Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 32.Europe Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Pharmaceutical Excipients Market Share (%), By Country, 2017-2031F
  • Figure 34.Germany Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 35.Germany Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 36.Germany Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 37.Germany Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 38.Germany Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 39.France Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 40.France Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 41.France Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 42.France Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 43.France Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 44.Italy Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 45.Italy Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 46.Italy Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 47.Italy Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 48.Italy Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 49.United Kingdom Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 50.United Kingdom Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 51.United Kingdom Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 52.United Kingdom Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 53.United Kingdom Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 54.Russia Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 55.Russia Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 56.Russia Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 57.Russia Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 58.Russia Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 59.Netherlands Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 60.Netherlands Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 61.Netherlands Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 62.Netherlands Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 63.Netherlands Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 64.Spain Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 65.Spain Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 66.Spain Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 67.Spain Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 68.Spain Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 69.Turkey Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 70.Turkey Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 71.Turkey Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 72.Turkey Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 73.Turkey Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 74.Poland Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 75.Poland Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 76.Poland Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 77.Poland Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 78.Poland Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 79.South America Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 80.South America Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 81.South America Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 82.South America Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 83.South America Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 84.South America Pharmaceutical Excipients Market Share (%), By Country, 2017-2031F
  • Figure 85.Brazil Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 86.Brazil Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 87.Brazil Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 88.Brazil Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 89.Brazil Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 90.Argentina Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 91.Argentina Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 92.Argentina Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 93.Argentina Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 94.Argentina Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 95.Asia-Pacific Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 96.Asia-Pacific Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 97.Asia-Pacific Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 98.Asia-Pacific Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 99.Asia-Pacific Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 100.Asia-Pacific Pharmaceutical Excipients Market Share (%), By Country, 2017-2031F
  • Figure 101.India Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 102.India Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 103.India Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 104.India Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 105.India Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 106.China Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 107.China Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 108.China Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 109.China Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 110.China Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 111.Japan Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 112.Japan Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 113.Japan Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 114.Japan Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 115.Japan Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 116.Australia Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 117.Australia Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 118.Australia Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 119.Australia Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 120.Australia Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 121.Vietnam Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 122.Vietnam Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 123.Vietnam Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 124.Vietnam Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 125.Vietnam Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 126.South Korea Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 127.South Korea Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 128.South Korea Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 129.South Korea Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 130.South Korea Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 131.Indonesia Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 132.Indonesia Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 133.Indonesia Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 134.Indonesia Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 135.Indonesia Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 136.Philippines Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 137.Philippines Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 138.Philippines Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 139.Philippines Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 140.Philippines Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 141.Middle East & Africa Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 142.Middle East & Africa Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 143.Middle East & Africa Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 144.Middle East & Africa Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 145.Middle East & Africa Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 146.Middle East & Africa Pharmaceutical Excipients Market Share (%), By Country, 2017-2031F
  • Figure 147.Saudi Arabia Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 148.Saudi Arabia Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 149.Saudi Arabia Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 150.Saudi Arabia Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 151.Saudi Arabia Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 152.UAE Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 153.UAE Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 154.UAE Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 155.UAE Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 156.UAE Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 157.South Africa Pharmaceutical Excipients Market, By Value, in USD Billion, 2017-2031F
  • Figure 158.South Africa Pharmaceutical Excipients Market, By Volume, in Million Units, 2017-2031F
  • Figure 159.South Africa Pharmaceutical Excipients Market Share (%), By Type, 2017-2031F
  • Figure 160.South Africa Pharmaceutical Excipients Market Share (%), By Functionality, 2017-2031F
  • Figure 161.South Africa Pharmaceutical Excipients Market Share (%), By End-user, 2017-2031F
  • Figure 162.By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163.By Functionality Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11263

Global pharmaceutical excipients market is projected to witness a CAGR of 7% during the forecast period 2024-2031F, growing from USD 11.11 billion in 2023 to USD 19.08 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Various factors, such as the increasing prevalence of chronic diseases among the global population and a rising geriatric population drive growth in the global pharmaceutical excipients market. Growing demand for generic drugs, along with increased investment and research and development activities by public and private firms, leads to the growth of this market. Moreover, a favorable regulatory system, the presence of several top players and collaborative venture activities, new entrants, and frequent new product launches accelerate the growth of the global pharmaceutical excipients market.

The global pharmaceutical excipients market is undergoing robust growth, primarily due to the increased prevalence of chronic and infectious diseases among the global population. The rising aging population increases the probability of being affected by chronic or infectious conditions due to lack of immunity, further accelerating demand for pharmaceutical products such as excipients for treating these diseases. Growth in the pharmaceutical industry and increasing demand for generic drugs to cater to the increasing demand for pharmaceutical products leads to increasing interest among pharmaceutical companies in investing in drug discovery using pharmaceutical excipients. Increased research and development activities by market players to develop new efficient pharmaceutical excipients, favorable regulatory frameworks, and frequent product launches by the market players play a pivotal role in enhancing the global pharmaceutical excipients market. Moreover, consistent collaboration activities such as mergers and acquisitions, partnerships, and distribution agreements between the organizations further propel the global pharmaceutical excipients market. For instance, in November 2023, IFF's and BASF's pharma solutions divisions announced a collaboration to bring IFF's leading pharmaceutical excipients brands on BASF's "ZoomLab", a virtual pharma assistant platform. This platform enables the researchers to predict and analyze the suitable excipients required for developing new pharmaceutical formulations and assists in overcoming formulation challenges.

Increase in Prevalence of Chronic Diseases

The demand for pharmaceutical excipients is increasing significantly due to the rising prevalence of chronic diseases. The increasing aging population is responsible for the onset of several chronic health conditions such as cardiovascular diseases, cancer, and diabetes. These chronic diseases are fatal and need cost-effective solutions to treat these diseases. According to WHO 2023 statistics, chronic diseases are the most common diseases affecting people from all over the world and are responsible for 41 million deaths every year worldwide. A sedentary lifestyle, unhealthy diet, obesity, excessive tobacco, and alcohol consumption are the leading risk factors for the rising prevalence of chronic diseases among the population. Pharmaceutical excipients are crucial in optimizing drug delivery formats and developing safe and cost-effective drugs. Moreover, key market players are consistently investing in developing innovative and efficient pharmaceutical excipients to cater to the needs of this growing population suffering from chronic health conditions. This is further accelerating the growth of the global pharmaceutical excipients market.

Increasing Demand for Generic Drugs

With the growing prevalence of chronic and infectious diseases worldwide, there is a huge demand for affordable medicines to cater to the needs of the growing diseased population. Pharmaceutical excipients play a significant role in developing cost-effective and safe generic drugs. As a result, the demand for pharmaceutical excipients is also increasing among the pharmaceutical manufacturers. Several leading pharmaceutical companies are consistently involved in the manufacturing of generic drugs. For instance, Teva Pharmaceutical Industries Ltd., which is a global leader in the pharmaceutical industry states that worldwide, around 200 million people take one of their generic medicines every day and a significant portion of the company's research and development budget is focused on developing generic medicines. This growing interest of the major players in investment activities in generic drugs is anticipated to propel the global pharmaceutical excipients market growth.

Pharmaceutical Companies Hold a Significant Market Share

Based on end-user, the pharmaceutical companies hold a significant share due to frequent product launches by the leading pharmaceutical companies. Furthermore, collaboration ventures such as mergers and acquisitions, and partnership agreements lead to faster growth of the pharmaceutical companies in this market. For instance, in July 2023, Roquette, a strong global player in naturally derived pharmaceutical excipients, announced the acquisition of Qualicaps, a Japan-based pharmaceutical company and the third-largest producer of hard capsules for oral dosage solutions. This strategic acquisition is expected to expand Roquette's global reach and enhance its business of pharmaceutical excipients. These frequent collaboration ventures among pharmaceutical companies bring innovation and advancements in pharmaceutical excipients and drive market growth.

Fillers and Diluents Segment Holds a Significant Market Share

Based on functionality, the fillers and diluents segment holds a significant market share in this market. Pharmaceutical excipient's functionality as a filler plays several important roles during drug formulations, especially in tablet and capsule production. Excipients as a fillers play an essential part in adding bulk to the formulations when the active ingredients are too small. For instance, in October 2023, Roquette, which is a market leader in developing pharmaceutical excipients announced the launch of three new pharmaceutical excipients named "LYCATAB CT-LM" partially pregelatinized starch, "MICROCEL 103 SD" and "MICROCEL 113 SD" microcrystalline cellulose. These excipients are multifunctional, offering functionalities such as binding, filler, and disintegrant that help in the development of drugs.

Asia-Pacific is Expected to be the Fastest Growing Region

Asia-Pacific region is expected to be the fastest-growing region in the global pharmaceutical excipients market. Rapidly increasing population and growing prevalence of chronic and infectious diseases in this region accelerate the demand for pharmaceutical products such as excipients, to improve drug discovery and enhance medical facilities. Asia-Pacific is an emerging market that has huge potential in the pharmaceutical industry, due to which key market players are continuously developing partnership collaborations and establishing operational facilities in this region to expand their business and enhance the overall growth of this market globally. For instance, in February 2022, Azelis, a global leading manufacturer of specialty chemicals, announced the expansion of its pharmaceutical business in India by signing a distribution agreement with Roquette, which is a global leader in providing pharmaceutical excipients. This distribution agreement will strengthen Azelis global footprint, and flourish the pharmaceutical excipients industry in Asia-Pacific.

Future Market Scenario (2024-2031F)

The global pharmaceutical excipients market is expected to grow in the future, due to several factors. Primarily, the increasing prevalence of chronic and infectious diseases is accelerating the demand for pharmaceutical products including excipients in the healthcare sector to provide safe and effective medicines. The growing generic drugs market, along with increased research and development activities by public and private organizations to develop efficient and cost-effective generic drugs by using excipients led to the growth of the global pharmaceutical excipients market. Additionally, frequent product launches, collaboration activities, and new entrants in this market are expected to drive market growth in the forecast period. For instance, in September 2023, IFF's Pharma Solutions announced the launch of leading excipient products such as low nitrite excipient solutions for the pharmaceutical industry. These consistent innovative product launches are expected to accelerate growth in this market.

Key Players Landscape and Outlook

In the pharmaceutical excipients market, several pharmaceutical companies are consistently involved in collaboration activities such as establishing strategic partnerships and undergoing distribution agreements, which play an essential role in propelling the global pharmaceutical excipients market's growth. These partnerships enable companies to gain informative insights on the market trends, access each other's knowledge, resources, markets, and technologies, and invest in research and development activities to bring highly efficient and cost-effective pharmaceutical products such as excipients to the market. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative ventures promote innovation, expedite product development, and contribute to the enduring and robust growth of the global market. For instance, in May 2023, Croda International Plc. announced that it has signed an exclusive license agreement with Amyris to supply biotechnology-derived "squalene" as an excipient to be used for various purposes such as vaccine development, drug delivery systems, or nucleic acid delivery systems. Amyris is a worldwide leading synthetic biology company, which will expedite the commercialization of squalene products to the global market, which will further assist in elevating the global pharmaceutical excipients market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Pharmaceutical Excipients Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Type
    • 4.2.1.Inorganic Chemicals
    • 4.2.2.Organic Chemicals
  • 4.3.By Functionality
    • 4.3.1.Binders and Adhesives
    • 4.3.2.Fillers and Diluents
    • 4.3.3.Coating Material
    • 4.3.4.Flavoring Agent
    • 4.3.5.Disintegrants
    • 4.3.6.Coloring Agents
    • 4.3.7.Preservatives
    • 4.3.8.Buffers
    • 4.3.9.Others
  • 4.4.By End-user
    • 4.4.1.Pharmaceutical Companies
    • 4.4.2.Research Organization and Academics
    • 4.4.3.Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Pharmaceutical Excipients Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Type
      • 5.1.2.1.Inorganic Chemicals
      • 5.1.2.2.Organic Chemicals
    • 5.1.3.By Functionality
      • 5.1.3.1.Binders and Adhesives
      • 5.1.3.2.Fillers and Diluents
      • 5.1.3.3.Coating Material
      • 5.1.3.4.Flavoring Agent
      • 5.1.3.5.Disintegrants
      • 5.1.3.6.Coloring Agents
      • 5.1.3.7.Preservatives
      • 5.1.3.8.Buffers
      • 5.1.3.9.Others
    • 5.1.4.By End-user
      • 5.1.4.1.Pharmaceutical Companies
      • 5.1.4.2.Research Organization and Academics
      • 5.1.4.3.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
        • 5.1.5.1.1.By Value
        • 5.1.5.1.2.By Volume
      • 5.1.5.2.By Type
        • 5.1.5.2.1.Inorganic Chemicals
        • 5.1.5.2.2.Organic Chemicals
      • 5.1.5.3.By Functionality
        • 5.1.5.3.1.Binders and Adhesives
        • 5.1.5.3.2.Fillers and Diluents
        • 5.1.5.3.3.Coating Material
        • 5.1.5.3.4.Flavoring Agent
        • 5.1.5.3.5.Disintegrants
        • 5.1.5.3.6.Coloring Agents
        • 5.1.5.3.7.Preservatives
        • 5.1.5.3.8.Buffers
        • 5.1.5.3.9.Others
      • 5.1.5.4.By End-user
        • 5.1.5.4.1.Pharmaceutical Companies
        • 5.1.5.4.2.Research Organization and Academics
        • 5.1.5.4.3.Others
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Type
  • 6.2.By Functionality
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Kerry Group plc.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.DFE Pharma GmbH & Co KG
  • 13.3.Cargill, Incorporated
  • 13.4.BASF SE
  • 13.5.Roquette Freres
  • 13.6.Pfanstiehl Inc.
  • 13.7.MEGGLE GmbH & Co. KG.
  • 13.8.The Lubrizol Corporation
  • 13.9.Avantor, Inc.
  • 13.10.BENEO GmbH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer